Kitisin, Thitinan
Muangkaew, Watcharamat
Sukphopetch, Passanesh
Funding for this research was provided by:
Mahidol University (contact no. A22/2564)
Mahidol University (contact no. BRF1-A45/2564, contact no. BRF2-NDFR 05/2564)
Mahidol University (contact no. BRF1-064)
Health Systems Research Institute (Grant number: HSRI 64-051)
Article History
Received: 21 March 2022
Accepted: 13 June 2022
First Online: 22 June 2022
Declarations
:
: This study was conducted under the Animal for Scientific Purposes Act, B.E. 2558 (A.D. 2015), Thailand. All of <i>C. elegans</i> strains were obtained from the Caenorhabditis Genetics Center, University of Minnesota, USA. All <i>C. elegans</i> procedures were performed using protocols approved by the Faculty of Tropical Medicine – Animal Care and Use Committee (FTM‐ACUC), Mahidol University, Thailand, No. FTM024-2020. Safe handling of <i>Cryptococcus neoformans</i> ATCC#32045 and <i>Cryptococcus gattii</i> ATCC#56992 strains were approved by Institutional Biosafety Committee, Faculty of Tropical Medicine, Mahidol University, Thailand, Submission No. FTM-IBC-20–09.
: Not applicable.
: The authors declare that they have no competing interests.